- Home
- CCIF vs RGC Comparison
CCIF vs RGC Comparison
Compare CCIF & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIF
- RGC
- Stock Information
- Founded
- CCIF 2011
- RGC 2014
- Country
- CCIF United States
- RGC Hong Kong
- Employees
- CCIF N/A
- RGC N/A
- Industry
- CCIF Finance/Investors Services
- RGC Medicinal Chemicals and Botanical Products
- Sector
- CCIF Finance
- RGC Health Care
- Exchange
- CCIF Nasdaq
- RGC Nasdaq
- Market Cap
- CCIF 111.9M
- RGC 105.3M
- IPO Year
- CCIF N/A
- RGC 2021
- Fundamental
- Price
- CCIF $8.28
- RGC $6.13
- Analyst Decision
- CCIF
- RGC
- Analyst Count
- CCIF 0
- RGC 0
- Target Price
- CCIF N/A
- RGC N/A
- AVG Volume (30 Days)
- CCIF 76.9K
- RGC 221.5K
- Earning Date
- CCIF 01-01-0001
- RGC 11-29-2024
- Dividend Yield
- CCIF 25.90%
- RGC N/A
- EPS Growth
- CCIF N/A
- RGC N/A
- EPS
- CCIF N/A
- RGC N/A
- Revenue
- CCIF N/A
- RGC N/A
- Revenue This Year
- CCIF N/A
- RGC N/A
- Revenue Next Year
- CCIF N/A
- RGC N/A
- P/E Ratio
- CCIF N/A
- RGC N/A
- Revenue Growth
- CCIF N/A
- RGC N/A
- 52 Week Low
- CCIF $7.43
- RGC $3.03
- 52 Week High
- CCIF $10.16
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- CCIF 52.45
- RGC 48.30
- Support Level
- CCIF $8.04
- RGC $6.08
- Resistance Level
- CCIF $8.32
- RGC $6.71
- Average True Range (ATR)
- CCIF 0.09
- RGC 1.34
- MACD
- CCIF 0.01
- RGC -0.10
- Stochastic Oscillator
- CCIF 85.71
- RGC 12.59
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing primarily in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting primarily of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.